Dr. Lironn D. Kraler, MD

Dr. Kraler practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Kraler's NPI, 1922419373, was assigned on May 19, 2014. Dr. Kraler graduated from Keck School of Medicine of USC in 2014. Dr. Kraler holds California license A142306.

Dr. Kraler's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Kraler's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Kraler is also affiliated with Santa Clara Valley Medical Center. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Kraler to 2 more hospitals and 1 medical group, each named with a free account. Dr. Kraler's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kraler practices, 4 sites in all. Vendor and product names are available with a free account.

Vascular neurology is Dr. Kraler's primary specialty in the NPI Registry, under taxonomy code 2084V0102X. Dr. Kraler is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Kraler is licensed in California.

Dmand AI lists acute mini-stroke (TIA), cerebrovascular disease, lower back pain, migraine and chronic headache, muscle pain, fibromyalgia, and limb pain, muscle weakness, neuropathy and stroke among the conditions Dr. Kraler treats.

CMS data shows 556 Medicare services from Dr. Kraler across 11 procedure codes in 2024, for 351 Medicare patients. Medicare paid $59,593 for them.

CMS counts 351 Medicare patients who saw Dr. Kraler in 2024. The largest group is 75 to 84, with 136 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 1.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kraler's median patient age at 63, with 47% women.

In 2024, Dr. Kraler wrote 159 Medicare Part D claims for 49 patients. 95% of them were for generic drugs. CMS names the drug for 88 of them, across 6 drugs with 11 or more claims each, at $3,624 in total drug cost. In 2023, CMS named 58 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Kraler for performance year 2024, reported as part of a group. Dr. Kraler accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kraler as offering telehealth.

Dmand AI links 7 papers to Dr. Kraler, published from 2018 to 2024. 2023 was the busiest year, with 2. The most frequent topics are Blood Pressure, Hypertension and Stroke. Dr. Kraler's most frequent co-authors are Carl Aaron Gold, MD, Kathryn Andrea Kvam, MD and Maarten G. Lansberg, MD.

Dmand AI links Dr. Kraler to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Stroke and Hypertension.

CMS Open Payments shows 1 general payment to Dr. Kraler from 1 drug or device company in 2023. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $20.

Dr. Kraler graduated from Keck School of Medicine of USC in 2014.

Dr. Kraler is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.